Clinical Study

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration

Table 3

Changes in visual acuity after PDT combined with IVR during 12 months.

Changes in logMAR from the baseline1 month3 months6 months12 months

0.3 logMAR units improvement7 eyes (18.4%)16 eyes (42.1%)14 eyes (36.8%)15 eyes (39.5%)
Changes under 0.3 logMAR units30 eyes (78.9%)21 eyes (55.3%)23 eyes (60.5%)21 eyes (55.3%)
≧0.3 logMAR units deterioration1 eye (2.6%)1 eye (2.6%)1 eye (2.6%)2 eyes (5.3%)

IVR: intravitreal injection of ranibizumab, PDT: photodynamic therapy.